A. Brugnera Nunes de Mattos, M. Maria Cerneski, S. Reichert, and C. Nava Jaeger, “Use of Adalimumab, a TNF-Alpha Inhibitor, is Associated with Paradoxical Psoriasis: Two Clinical Case Reports ”, Braz J Case Rep., vol. 3, no. 2, pp. 12–15, Jan. 2023.